S&P 500   4,690.25 (+2.15%)
DOW   35,748.77 (+1.48%)
QQQ   398.13 (+3.09%)
AAPL   170.46 (+3.11%)
MSFT   335.25 (+2.78%)
FB   324.10 (+1.96%)
GOOGL   2,944.99 (+2.86%)
AMZN   3,541.46 (+3.33%)
TSLA   1,048.44 (+3.91%)
NVDA   321.88 (+7.16%)
BABA   125.04 (+1.17%)
NIO   33.36 (+3.15%)
CGC   10.85 (+6.90%)
AMD   145.44 (+4.59%)
GE   98.14 (+2.22%)
MU   86.55 (+4.97%)
T   23.12 (-0.69%)
F   19.94 (+3.75%)
DIS   150.53 (+0.11%)
PFE   51.35 (-0.25%)
AMC   31.32 (+8.79%)
ACB   6.44 (+7.87%)
BA   211.43 (+2.70%)
S&P 500   4,690.25 (+2.15%)
DOW   35,748.77 (+1.48%)
QQQ   398.13 (+3.09%)
AAPL   170.46 (+3.11%)
MSFT   335.25 (+2.78%)
FB   324.10 (+1.96%)
GOOGL   2,944.99 (+2.86%)
AMZN   3,541.46 (+3.33%)
TSLA   1,048.44 (+3.91%)
NVDA   321.88 (+7.16%)
BABA   125.04 (+1.17%)
NIO   33.36 (+3.15%)
CGC   10.85 (+6.90%)
AMD   145.44 (+4.59%)
GE   98.14 (+2.22%)
MU   86.55 (+4.97%)
T   23.12 (-0.69%)
F   19.94 (+3.75%)
DIS   150.53 (+0.11%)
PFE   51.35 (-0.25%)
AMC   31.32 (+8.79%)
ACB   6.44 (+7.87%)
BA   211.43 (+2.70%)
S&P 500   4,690.25 (+2.15%)
DOW   35,748.77 (+1.48%)
QQQ   398.13 (+3.09%)
AAPL   170.46 (+3.11%)
MSFT   335.25 (+2.78%)
FB   324.10 (+1.96%)
GOOGL   2,944.99 (+2.86%)
AMZN   3,541.46 (+3.33%)
TSLA   1,048.44 (+3.91%)
NVDA   321.88 (+7.16%)
BABA   125.04 (+1.17%)
NIO   33.36 (+3.15%)
CGC   10.85 (+6.90%)
AMD   145.44 (+4.59%)
GE   98.14 (+2.22%)
MU   86.55 (+4.97%)
T   23.12 (-0.69%)
F   19.94 (+3.75%)
DIS   150.53 (+0.11%)
PFE   51.35 (-0.25%)
AMC   31.32 (+8.79%)
ACB   6.44 (+7.87%)
BA   211.43 (+2.70%)
S&P 500   4,690.25 (+2.15%)
DOW   35,748.77 (+1.48%)
QQQ   398.13 (+3.09%)
AAPL   170.46 (+3.11%)
MSFT   335.25 (+2.78%)
FB   324.10 (+1.96%)
GOOGL   2,944.99 (+2.86%)
AMZN   3,541.46 (+3.33%)
TSLA   1,048.44 (+3.91%)
NVDA   321.88 (+7.16%)
BABA   125.04 (+1.17%)
NIO   33.36 (+3.15%)
CGC   10.85 (+6.90%)
AMD   145.44 (+4.59%)
GE   98.14 (+2.22%)
MU   86.55 (+4.97%)
T   23.12 (-0.69%)
F   19.94 (+3.75%)
DIS   150.53 (+0.11%)
PFE   51.35 (-0.25%)
AMC   31.32 (+8.79%)
ACB   6.44 (+7.87%)
BA   211.43 (+2.70%)
NASDAQ:AKYA

Akoya Biosciences SEC Filings & 10K Form

$13.26
+0.52 (+4.08%)
(As of 12/7/2021 01:51 PM ET)
Add
Compare
Today's Range
$12.68
$13.35
50-Day Range
$11.37
$21.00
52-Week Range
$11.12
$28.96
Volume
3,188 shs
Average Volume
141,431 shs
Market Capitalization
$493.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Akoya Biosciences (NASDAQ:AKYA) SEC Filings

DateFilerForm TypeView
09/20/2021
7:51 PM
Akoya Biosciences (Issuer)
LAI GOLDMAN MYLA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2021
7:48 PM
Akoya Biosciences (Issuer)
LAI GOLDMAN MYLA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2021
3:17 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4/A
06/16/2021
3:38 PM
Akoya Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2021
8:59 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
8:58 PM
Akoya Biosciences (Issuer)
Mendel Scott (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/28/2021
3:01 PM
Akoya Biosciences (Subject)
Telegraph Hill Partners III, L.P. (Filed by)
Form SC 13G
05/25/2021
8:56 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:55 PM
Akoya Biosciences (Issuer)
SCHNETTLER THOMAS P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:54 PM
Akoya Biosciences (Issuer)
Raffin Thomas A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:53 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
8:53 PM
Akoya Biosciences (Issuer)
Nolan Garry Ph.D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2021
10:03 AM
Akoya Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/21/2021
8:38 PM
Akoya Biosciences (Issuer)
Nolan Garry Ph.D. (Reporting)
Form 3/A
04/20/2021
6:52 PM
Akoya Biosciences (Issuer)
SCHNETTLER THOMAS P (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:51 PM
Akoya Biosciences (Issuer)
Lashkari Deval (Reporting)
MACKOWSKI J MATTHEW (Reporting)
Raffin Thomas A. (Reporting)
Telegraph Hill Partners III Investment Management, LLC (Reporting)
Telegraph Hill Partners III, L.P. (Reporting)
Telegraph Hill Partners Management Company, LLC (Reporting)
THP III Affiliates Fund, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:50 PM
Akoya Biosciences (Issuer)
SHEPLER ROBERT G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:50 PM
Akoya Biosciences (Issuer)
Ramachandran Niro Ph.D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:49 PM
Akoya Biosciences (Issuer)
Winkler Matthew (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:48 PM
Akoya Biosciences (Issuer)
DRISCOLL JOSEPH (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:48 PM
Akoya Biosciences (Issuer)
Nolan Garry Ph.D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:47 PM
Akoya Biosciences (Issuer)
Pla Frederic (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/20/2021
6:46 PM
Akoya Biosciences (Issuer)
McKelligon Brian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2021
11:15 PM
Akoya Biosciences (Filer)
Form EFFECT
04/15/2021
3:33 PM
Akoya Biosciences (Filer)
Form CERT
04/15/2021
12:33 PM
Akoya Biosciences (Filer)
Form 8-A12B
04/12/2021
5:03 AM
Akoya Biosciences (Filer)
Form S-1/A
10/02/2018
2:58 PM
Akoya Biosciences (Filer)
Form D
Notice of Exempt Offering of Securities 
This page was last updated on 12/7/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.